Poinsettia Pharmaceutical Ambroxol Hydrochloride Drops Approved for Production

Medical Network, March 18 News On March 15th, Poinsettia issued an announcement stating that the wholly-owned subsidiary Guangzhou Poinsettia Pharmaceutical's Ambroxol Hydrochloride Drops was approved for production, and the product is an exclusive dosage form in China
.
Ambroxol is a commonly used expectorant.
According to data from Meinenet, the terminal sales of ambroxol in China's public medical institutions exceeded 7 billion yuan in 2019
.
Ambroxol is a very classic and commonly used expectorant in clinical practice, with a history of more than 40 years
.
Ambroxol hydrochloride has the properties of promoting mucus elimination and dissolving secretions, can promote the elimination of thick secretions in the respiratory tract and reduce mucus retention, thereby promoting sputum and improving respiratory conditions
.
According to data from Menet.
com, in 2019, the sales of terminal ambroxol in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (Chinese public medical institutions) exceeded 7 billion yuan, and the original research manufacturer Boehringer Ingelheim occupied 18.
76.
% Market share
.
In 2020H1, the sales of terminal ambroxol in public medical institutions in China exceeded 2.
2 billion yuan, a year-on-year decline of 42.
37%
.
Source of sales of terminal ambroxol in public medical institutions in China: Mynet.
com.
Competitive landscape of terminal ambroxol in public medical institutions in China.
Ambroxol hydrochloride includes various dosage forms such as oral solutions, tablets, and injections
.
At present, 6 varieties of ambroxol hydrochloride market have been reviewed, including ambroxol hydrochloride drops, ambroxol hydrochloride dispersible tablets, ambroxol hydrochloride capsules, ambroxol hydrochloride injection, ambroxol hydrochloride tablets, and ammonia hydrochloride Bromoxol nebulized inhalation solution
.
Among them, oral regular-release dosage forms and injections have been included in the third and fourth batches of centralized procurement, respectively
.
Ambroxol hydrochloride drops are suitable for people who have thick sputum that is difficult to cough up, including young children .
The instructions indicate the specific usage and dosage of children
.
Poinsettia's ambroxol hydrochloride drops are the first domestically reviewed ambroxol hydrochloride oral liquid preparation, and the dosage form is currently the exclusive domestic one
.
According to data, the product line of poinsettia is mainly used for children's medicine and chronic disease medicine
.
The approval of ambroxol hydrochloride drops will further enrich the company's pipeline and categories of children's medicine products and enhance the company's competitiveness in the field of children's medicine
.
Source: Minet.
com database, company announcement